Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to Public Health England's 2020 report, Sugar reduction: progress report, 2015 to 2019, what assessment he has made of the potential effect of the launch of the Office for Health Improvement and Disparities on the expected publication date of the final report on the impact of the UK voluntary sugar reformulation programme; and if he will make a statement.
Answered by Maggie Throup
The transfer of the voluntary reduction and reformulation programme from Public Health England to the Office of Health Promotion and Disparities means the expected publication date of the fourth progress report for the sugar reduction programme will be early in 2022.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the total cost to the NHS of patient transport for in-centre dialysis patients in each of the past five years.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
No such recent estimate has been made. The information is not held in the format requested.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the (a) health benefits to patients and (b) costs of opening dialysis centres from six to seven days per week; and if he will make a statement.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The average yearly cost per patient (a) in-centre and (b) home-dialysis, including the cost of treatment and management, is below:
The information quoted relates to the National Health Service (NHS) in England only. Devolved Administrations will differ. All costs will be indicative only, as Market Forces Factor (MFF), transport costs, planned outpatient review and non-elective care will differ between patients and provider contracts.
No recent assessment of the cost benefit of home dialysis compared to in-centre has been made. Assessing such cost benefits to the NHS are part of the Renal Services Transformation Programme (RSTP), which commenced by NHS England in 2021. Cost benefit analysis will vary between providers based upon transport costs and existing demand and capacity constraints in local NHS facilities.
As outlined in the March 2021 Getting It Right First Time Programme National Specialty Report for Renal Medicine, there is a strong preference amongst patients for home dialysis. This is why one of the strategic aims of the RSTP is to increase the percentage of patients per centre receiving home therapies to 20%.
No recent estimate of the health benefits to patients or costs of opening dialysis centres from six to seven days per week has been made.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his most recent assessment is of the cost benefit to the NHS of the provision of dialysis services in a patient's home compared to dialysis services in-centre.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The average yearly cost per patient (a) in-centre and (b) home-dialysis, including the cost of treatment and management, is below:
The information quoted relates to the National Health Service (NHS) in England only. Devolved Administrations will differ. All costs will be indicative only, as Market Forces Factor (MFF), transport costs, planned outpatient review and non-elective care will differ between patients and provider contracts.
No recent assessment of the cost benefit of home dialysis compared to in-centre has been made. Assessing such cost benefits to the NHS are part of the Renal Services Transformation Programme (RSTP), which commenced by NHS England in 2021. Cost benefit analysis will vary between providers based upon transport costs and existing demand and capacity constraints in local NHS facilities.
As outlined in the March 2021 Getting It Right First Time Programme National Specialty Report for Renal Medicine, there is a strong preference amongst patients for home dialysis. This is why one of the strategic aims of the RSTP is to increase the percentage of patients per centre receiving home therapies to 20%.
No recent estimate of the health benefits to patients or costs of opening dialysis centres from six to seven days per week has been made.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average yearly cost per patient is of (a) in-centre and (b) home-dialysis, including the cost of treatment and management.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The average yearly cost per patient (a) in-centre and (b) home-dialysis, including the cost of treatment and management, is below:
The information quoted relates to the National Health Service (NHS) in England only. Devolved Administrations will differ. All costs will be indicative only, as Market Forces Factor (MFF), transport costs, planned outpatient review and non-elective care will differ between patients and provider contracts.
No recent assessment of the cost benefit of home dialysis compared to in-centre has been made. Assessing such cost benefits to the NHS are part of the Renal Services Transformation Programme (RSTP), which commenced by NHS England in 2021. Cost benefit analysis will vary between providers based upon transport costs and existing demand and capacity constraints in local NHS facilities.
As outlined in the March 2021 Getting It Right First Time Programme National Specialty Report for Renal Medicine, there is a strong preference amongst patients for home dialysis. This is why one of the strategic aims of the RSTP is to increase the percentage of patients per centre receiving home therapies to 20%.
No recent estimate of the health benefits to patients or costs of opening dialysis centres from six to seven days per week has been made.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
What steps his Department is taking to help ensure adequate investment in eating disorder research.
Answered by Gillian Keegan - Secretary of State for Education
Mental health research is a strategic priority for the Departmental-funded National Institute for Health Research. We are increasing year on year spend in mental health research and invested £93 million in 2019/2020. We also fund the Eating Disorders Genetic Initiative, one of the largest eating disorders studies in England. In partnership with Beat, it aims to better understand what may lead to an eating disorder and how to improve treatments, both prevention and intervention.